Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GCAGGTCCCCTAGAAGAAGAACTCCCTCGCCTCGCAGACGAAGGTCTCAATCGCCGCGTCGCAGAAGATCTCAATCTCGGGAATCTCAATGTTAGTATTC| |CTTGGACTCATAAGGTGGGGAACTTTACTGGGCTTTATTCTTCTACTGTACCTGTCTTTAATCCTCATTGGAAAACACCATCTTTTCCTAATATACATTT
End
35671796/35180893 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/58129; hsa-let-7e/Downstream/164620;
Upstream sequence
tggaatgatggcactcagaactttaccttcccagctctggttctgtataagggacttgaaagcttctgtgagtggtggccctgaaagaaacttgtatttc
Downstream sequence
ccatagtcatagggctgagatttctgaaaaccaaagctaaagtctaatccaacaaaagttgaacttctaacctcacagggtcttttttgttaaagttagg
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.